Cannabis Capital Corp. (CBCA) Changes Name to Crown Baus Capital Corp., Better Reflecting Corporate Initiatives and Long-term Projects

BEVERLY HILLS, Calif., July 17, 2014 /PRNewswire/ -- Cannabis Capital Corp. (OTCBB: CBCA) is a global acquisition-based conglomerate targeting five primary industries:  High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.  The Company is pleased to announce that its Board of Directors has selected the name Crown Baus Capital Corp. to better reflect the company's existing and prospective ventures in these five business sectors.  Simultaneous with this announcement of the corporate name change, the Company's website has been launched.

The name change began with appropriate regulatory filings with the Office of the Nevada Secretary of State and the name change is currently before the Financial Industry Regulatory Authority (FINRA).  No symbol change is anticipated.  Further, the Crown Baus Capital Corp. name change will have no effect on the Company's share structure or corporate organization.

The Company recently acquired WebCongress, Inc. as a wholly-owned subsidiary.  WebCongress produces global digital marketing and strategy events, including high-tech educational and consulting programs, attracting technology professionals from start-ups to Fortune 100 corporations, including such companies as Google, Facebook, Twitter, YouTube, Spotify, Blackberry, Microsoft, Skype, Samsung, Intel, and Ericsson. 

CBCA has also partnered in the expanding Medical Marijuana Industry seeking to finance FDA-level drug research and development with companies such as Cannabis Science, Inc. (CBIS).  Cannabis Science has already demonstrated success with self-medicating cannabis patients suffering from various cancers, and Crown Baus intends to invest to support groundbreaking clinical trials to further this success.

Crown Baus is also establishing financial and partnership relationships in the media and entertainment sector.  Final negotiations are underway for the Company to purchase an incubator-status television network, a movie studio, and a record label to support its aggressive media exposure department.

President & CEO of Crown Baus Capital Corp., Chad S. Johnson, Esq., stated, "The Company will be persistent in pursuing new opportunities and partnerships within multiple growth industries, identifying synergistic relationships across sectors with a high growth strategy."

About Crown Baus Capital Corp.

Crown Baus Capital Corp. (CBCA) is a global acquisition-based conglomerate targeting five primary industries:  High-Tech Incubation, Drug Development, Entertainment/Media, Education, and Financial Services.  The Company is based in the United States but is already operating globally through its subsidiary, WebCongress, Inc., and Company partners.  Crown Baus seeks to add shareholder value through cross-industry synergies and strategic growth.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as "anticipate," "seek," intend," "believe," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Crown Baus Capital Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Crown Baus Capital Corp.
Chad S. Johnson, Esq., Director, President & CEO
+1 866.784.7239

Investment Inquiries
Robert Kane, Director & CFO
+1 561.420.4824


SOURCE Cannabis Capital Corp.


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.


PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.